2nd Quarter - Report

WILLIAMS AND JENSEN, PLLC for PHRMA

Firm
Client
Income
$50,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Medicare/Medicaid MMM

General education about policies impacting pharmaceutical development, approval and reimbursement. Non-interference. Rebates for Medicare Part D. Importation. 340B Drug Pricing Program. 21st Century Cures Initiative. H.R. 2 Medicare Access and CHIP Reauthorization Act of 2015. H.R. 1021, Protecting the Integrity of Medicare Act. CMMI Medicare Part B Demonstration.

LobbyistCovered position, as disclosed
JACK STEVEN HART —
SUSAN HIRSCHMANN —
MATTHEW B HOEKSTRA —
CHERYL LYNN JAEGER —
ANDREW JONES Legislative Counsel, Rep. Hinojosa; Legislative Director and Counsel, Rep. Lujan
KARINA LYNCH —
ERIN BOOK MULLEN —
GEORGE OLSEN —
FRANK VLOSSAK New LA, Rep. Merrill Cook

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1021 (114th), H.R. 2 (114th)

Health Issues HCR

21st Century Cures Initiative, H.R. 6.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN —
CHERYL LYNN JAEGER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 6 (114th)

Budget/Appropriations BUD

Issues related to pharmaceutical development.

LobbyistCovered position, as disclosed
SUSAN HIRSCHMANN New COS, Rep Van Hilleary and Majority Whip
CHERYL LYNN JAEGER New Shrd employee, Ofc of the Speaker & Ofc of VA 7; Sr Policy Adv, Maj Leader, Rep Cantor; Sr. Policy Adv, Republican Whip, Rep Cantor; Sr. Policy Adv, Maj Whip, Rep Roy Blunt; Prof Staff House Committee E&C; SR LA Rep Cox.

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.